Versican Secreted by Cancer-Associated Fibroblasts is a Poor Prognostic Factor in Hepatocellular Carcinoma.
Koichi KatoMoto FukaiKanako C HatanakaAkira TakasawaTomoyuki AoyamaTakahiro HayasakaYoshihiro MatsunoToshiya KamiyamaYutaka HatanakaAkinobu TaketomiPublished in: Annals of surgical oncology (2022)
VCAN secreted from CAFs promoted malignant transformation of HCC cells and has potential as a new therapeutic target in HCC.